Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Sep 27, 2022
- Accession no.
- 0001209191-22-051310
- Filed
- Sep 27, 2022, 7:29 AM ET
- Trade date
- Sep 26, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $90.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2022 | Common Stock | PPurchaseAcquired | +1,709 | $1.79 | +$3,050.57 | 197,708,403 | Indirect | |
| Sep 26, 2022 | Common Stock | PPurchaseAcquired | +23,291 | $1.79 | +$41,690.89 | 197,731,694 | Indirect | |
| Sep 26, 2022 | Common Stock | PPurchaseAcquired | +2,400 | $1.81 | +$4,332 | 197,734,094 | Indirect | |
| Sep 26, 2022 | Common Stock | PPurchaseAcquired | +22,600 | $1.81 | +$40,906 | 197,756,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.